ASCO GU 2025: Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities
A new study from the UK found that a mobile prostate cancer screening clinic called…
Browsing: ASCO
ASCO GU 2025: Talazoparib and enzalutamide combination improves survival in some patients with prostate cancer
Patients with castration-resistant metastatic prostate cancer with or without HRR gene alterations treated with a…
ASCO GU 2025: ENZA-p combination treatment improves survival for metastatic prostate cancer
New research findings were reported today from the ENZA-p study (ANZUP 1901), led by the…
The OJC Episode 7: ASCO Special Episode Part 2
Welcome to Episode 6 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for the first ASCO 2024 Special.
The OJC Episode 6: ASCO Special Episode Part 1
Welcome to Episode 6 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for the first ASCO 2024 Special.
ASCO 2024: Novel CAR T cell therapy obe-cel yields strong remission rates in adults with relapsed or refractory B-ALL
The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene autoleucel (obe-cel) achieved durable remissions…
ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal cancer
For patients with locally advanced oesophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment…
ASCO 2024: Trastuzumab deruxtecan significantly improves progression-free survival In breast cancer patients previously treated with endocrine therapy
Trastuzumab deruxtecan delays cancer growth for people with hormone receptor-positive (HR+), human epidermal growth factor…
ASCO 2024: Telehealth as effective as in-person care for early palliative treatment in patients with advanced lung cancer
New research reinforces telehealth delivery of palliative care as an effective alternative to in-person visits…
ASCO 2024: CAR T-cell therapy shows promise in patients with central nervous system lymphoma
A CAR T-cell therapy approved for patients with large B cell lymphoma has produced positive…